Inactive Instrument

Luminex Corporation

Equities

LMNX

US55027E1029

Advanced Medical Equipment & Technology

Russell Bradley to Resign as Senior Vice President of Corporate Development and Chief Marketing Officer of Luminex Corporation, Effective from June 30, 2016

May 03, 2016 at 01:47 am IST

On May 2, 2016, Russell Bradley informed Luminex Corporation of his intention to resign as Senior Vice President of Corporate Development and Chief Marketing Officer, effective June 30, 2016, for personal reasons.

Latest news about Luminex Corporation

Cytek Biosciences, Inc. completed the acquisition of Flow Cytometry & Imaging business unit of Luminex Corporation for $44.9 million.	28/23/28	CI
Transcript : Cytek Biosciences, Inc., Luminex Corporation - M&A Call	14/23/14
Cytek Biosciences, Inc. entered into an agreement to acquire Flow Cytometry & Imaging business unit of Luminex Corporation for $46.5 million.	13/23/13	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600 Health Care	15/21/15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 1000	15/21/15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P TMI Index	15/21/15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Global BMI Index	15/21/15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Composite 1500	15/21/15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600	15/21/15	CI
Luminex Corporation Announces Executive Changes	14/21/14	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Composite Index	14/21/14	CI
DiaSorin S.p.A. completed the acquisition of Luminex Corporation from BlackRock, Inc., Biomedical Advanced Research And Development Authority, The Vanguard Group, Inc., RGM Capital, LLC and others.	14/21/14	CI
Update: Middlesex Water to Replace Luminex in S&P SmallCap 600 -- Shares Jump in Pre-Market Trading	13/21/13	MT
Middlesex Water : to Replace Luminex in S&P SmallCap 600	13/21/13	MT
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Biotechnology Index	13/21/13	CI
Middlesex Water : S&P Dow Jones Indices Says Middlesex Water Company (MSEX) to Replace Luminex (LMNX) in S&P SmallCap 600 from July 15	13/21/13	MT
Luminex : Gets US Regulatory Approval for Acquisition by DiaSorin	09/21/09	MT
Luminex : Quarterly Dividend Unchanged at $0.10 Per Share, Payable July 8 to Stockholders of Record on June 17	21/21/21	MT
Luminex Corporation Declared Cash Dividend for the Second Quarter of 2021, Payable on July 8, 2021	21/21/21	CI
Luminex Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	05/21/05	CI
LUMINEX : Piper Sandler Downgrades Luminex to Neutral From Overweight; Price Target is $37	13/21/13	MT
LUMINEX : BTIG Downgrades Luminex to Neutral From Buy	13/21/13	MT
Sector Update: Health Care Stocks Slip as Midday Gains Evaporate	13/21/13	MT
Sector Update: Health Care Stocks Drifting Higher This Afternoon	12/21/12	MT
Sector Update: Health Care	12/21/12	MT

Chart Luminex Corporation

Duration

Period

More charts

Company Profile

Luminex Corporation is a United States-based company that is a biotechnology company. The Company is involved in developing, manufacturing and marketing biological testing technologies in the clinical diagnostic and life science industries. Its offer a solution applicable in the markets, including clinical diagnostics, pharmaceutical drug discovery, genomic and proteomic research, biomedical research and food safety.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+6.02%	22TCr
DANAHER CORPORATION	+9.25%	19TCr
INTUITIVE SURGICAL, INC.	+19.58%	14TCr
BOSTON SCIENTIFIC CORPORATION	+29.74%	11TCr
SIEMENS HEALTHINEERS AG	+1.63%	6.48TCr
EDWARDS LIFESCIENCES CORPORATION	+15.27%	5.24TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.69%	4.99TCr
AGILENT TECHNOLOGIES, INC.	-5.47%	4.26TCr
GE HEALTHCARE TECHNOLOGIES INC.	+1.58%	3.58TCr

Other Advanced Medical Equipment & Technology